CLINICAL_TRIALS
trial_result
· 2013-03-12
Clinical Trial Update: ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases [Phase 2]
Summary
Phase 2 trial of sagopilone (ZK219477) in patients with breast cancer and brain metastases was terminated; results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nancy Lin, MD | Conditions: Breast Cancer, CNS Disease | Phase 2 | Status: TERMINATED | Results posted: 2013-03-12